Last updated: 15:40
No Notes Added Yet
Here is a structured overview of Biopol Chemicals Ltd. based on the limited information provided:
Biopol Chemicals Ltd.
Ticker: BIOPOL
Country: India
Sector: Chemicals
Industry: Chemicals
1. Business Overview
Biopol Chemicals Ltd. is an Indian chemical company involved in the manufacturing and sale of various chemical products. While specific product lines are not detailed, the "Biopol" name might suggest a focus on polymers, specialty chemicals, or biologically-derived chemical compounds. The company's core business model is likely B2B, supplying raw materials, intermediates, or finished chemical products to a diverse range of end-user industries such as pharmaceuticals, agriculture, construction, automotive, textiles, or consumer goods. It makes money by producing and selling these chemical products, typically leveraging its manufacturing capabilities and process expertise.
2. Key Segments / Revenue Mix
Specific key segments or their revenue contribution are not available. In the broader chemicals sector, companies often segment their operations by product type (e.g., basic chemicals, specialty chemicals, agrochemicals, polymers), end-use application, or geographical markets. Without further information, it is not possible to detail Biopol Chemicals Ltd.'s revenue mix.
3. Industry & Positioning
The Indian chemicals industry is vast and diverse, encompassing bulk chemicals, specialty chemicals, petrochemicals, agrochemicals, and pharmaceuticals. It is characterized by capital-intensive operations, significant R&D spending in specialty segments, and vulnerability to raw material price fluctuations. The industry benefits from India's growing domestic demand and its potential as a global manufacturing hub. Biopol Chemicals Ltd. operates within this competitive landscape, likely contending with both large domestic players and international chemical giants, as well as numerous smaller local manufacturers. Its specific positioning (e.g., market leader in a niche, a broad-based player) cannot be determined without details on its product portfolio and market share.
4. Competitive Advantage (Moat)
Without specific company details, it's challenging to identify concrete competitive advantages for Biopol Chemicals Ltd. Potential moats in the chemicals sector could include:
Cost Advantages/Scale: Efficient manufacturing processes, large-scale production, or favorable access to raw materials.
Proprietary Technology/R&D: Unique formulations, patents, or specialized manufacturing processes, particularly in specialty chemicals.
Switching Costs: Strong, long-term customer relationships built on customized products or integrated supply chains.
Regulatory Barriers: Approvals for specific products or complex environmental compliance that deter new entrants.
Whether Biopol Chemicals Ltd. possesses any of these durable advantages cannot be confirmed without further information.
5. Growth Drivers
Key factors that could drive Biopol Chemicals Ltd.'s growth over the next 3-5 years include:
Domestic Economic Growth: A robust Indian economy fuels demand across various end-user industries (e.g., construction, automotive, consumer goods) that rely on chemical inputs.
"Make in India" Initiative: Government push for local manufacturing can increase demand for domestically produced chemicals, reducing reliance on imports.
Infrastructure Development: Large-scale infrastructure projects require various chemical products (e.g., for construction, paints, coatings).
Expansion into Specialty Chemicals: Shifting focus towards higher-margin specialty chemicals can enhance profitability and reduce cyclicality compared to basic chemicals.
Export Opportunities: Leveraging cost efficiencies or specialized products to cater to international markets.
6. Risks
Biopol Chemicals Ltd. faces several key business risks inherent to the chemicals industry:
Raw Material Price Volatility: Fluctuations in the prices of key raw materials (e.g., crude oil, natural gas, metals) can significantly impact production costs and profitability.
Environmental & Regulatory Risks: Stringent environmental regulations and compliance costs, along with potential liabilities from chemical incidents.
Economic Cyclicality: Demand for many chemical products is tied to the broader economy and industrial output, making the business susceptible to economic downturns.
Intense Competition: Competition from domestic and international players can lead to pricing pressure and margin erosion.
Currency Fluctuations: For companies involved in exports or imports of raw materials, adverse movements in foreign exchange rates can impact profitability.
Technological Obsolescence: Rapid advancements in chemical processes or materials could render existing technologies less competitive.
7. Management & Ownership
As a company in India, Biopol Chemicals Ltd. is likely to have a promoter-led management structure, where the founding family or group holds a significant ownership stake and plays a crucial role in strategic decision-making. The quality of management would depend on their experience, vision, governance practices, and ability to navigate industry challenges. Ownership is typically a mix of promoter holdings, institutional investors, and public shareholders, with promoter holdings often being substantial. Specific details on the quality or background of the management team and precise ownership structure are not available.
8. Outlook
Biopol Chemicals Ltd. operates in a sector with significant growth potential, driven by India's expanding economy, industrialization, and favorable government initiatives like 'Make in India'. This positive macro environment could provide a strong tailwind for the company's growth, especially if it focuses on value-added specialty chemicals or capitalizes on export opportunities. However, the chemical industry is inherently cyclical and exposed to volatility in raw material prices, intense competition, and stringent environmental regulations. The company's ability to maintain profitability will depend on its operational efficiency, cost management, product innovation, and capacity to adapt to changing market dynamics and regulatory landscapes. Its long-term success will hinge on effectively mitigating these risks while capitalizing on market opportunities.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹136 Cr.
Stock P/E 31.4
P/B 2.7
Current Price ₹125.8
Book Value ₹ 46.2
Face Value 10
52W High ₹133.8
Dividend Yield 0%
52W Low ₹ 84.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 17 | 49 | |
| Other Income | 0 | 0 | |
| Total Income | 17 | 49 | |
| Total Expenditure | 16 | 43 | |
| Operating Profit | 2 | 7 | |
| Interest | 0 | 1 | |
| Depreciation | 0 | 0 | |
| Exceptional Income / Expenses | 0 | 0 | |
| Profit Before Tax | 2 | 6 | |
| Provision for Tax | 0 | 1 | |
| Profit After Tax | 1 | 4 | |
| Adjustments | 0 | 0 | |
| Profit After Adjustments | 1 | 4 | |
| Adjusted Earnings Per Share | 1.6 | 5.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 188% | 0% | 0% | 0% |
| Operating Profit CAGR | 250% | 0% | 0% | 0% |
| PAT CAGR | 300% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 38% | 26% | 26% | 26% |
| ROCE Average | 38% | 26% | 26% | 26% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 9 | 14 |
| Minority's Interest | 0 | 0 |
| Borrowings | 0 | 1 |
| Other Non-Current Liabilities | 0 | 0 |
| Total Current Liabilities | 8 | 17 |
| Total Liabilities | 18 | 31 |
| Fixed Assets | 0 | 0 |
| Other Non-Current Assets | 0 | 0 |
| Total Current Assets | 17 | 31 |
| Total Assets | 18 | 31 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 |
| Cash Flow from Operating Activities | -9 | -2 |
| Cash Flow from Investing Activities | -0 | -0 |
| Cash Flow from Financing Activities | 9 | 3 |
| Net Cash Inflow / Outflow | 0 | 1 |
| Closing Cash & Cash Equivalent | 0 | 1 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 1.62 | 5.47 |
| CEPS(Rs) | 1.67 | 5.56 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 11.63 | 17.1 |
| Core EBITDA Margin(%) | 10.76 | 13.3 |
| EBIT Margin(%) | 10.53 | 13.2 |
| Pre Tax Margin(%) | 9.82 | 11.81 |
| PAT Margin (%) | 7.35 | 8.81 |
| Cash Profit Margin (%) | 7.58 | 8.96 |
| ROA(%) | 7.31 | 17.69 |
| ROE(%) | 13.92 | 38.1 |
| ROCE(%) | 14.37 | 38.16 |
| Receivable days | 212.12 | 99.51 |
| Inventory Days | 128.41 | 66.67 |
| Payable days | 95.77 | 56.07 |
| PER(x) | 0 | 0 |
| Price/Book(x) | 0 | 0 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 0.65 | 0.29 |
| EV/Core EBITDA(x) | 6.08 | 2.2 |
| Net Sales Growth(%) | 0 | 181.82 |
| EBIT Growth(%) | 0 | 253.24 |
| PAT Growth(%) | 0 | 238.08 |
| EPS Growth(%) | 0 | 238.08 |
| Debt/Equity(x) | 0.39 | 0.57 |
| Current Ratio(x) | 2.08 | 1.81 |
| Quick Ratio(x) | 1.34 | 1.12 |
| Interest Cover(x) | 14.8 | 9.52 |
| Total Debt/Mcap(x) | 0 | 0 |
| # | Mar 2026 |
|---|---|
| Promoter | 65.81 |
| FII | 9.3 |
| DII | 2.92 |
| Public | 21.98 |
| Others | 0 |
| Total | 100 |
| # | Mar 2026 |
|---|---|
| Promoter | 0.71 |
| FII | 0.1 |
| DII | 0.03 |
| Public | 0.24 |
| Others | 0 |
| Total | 1.08 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.